Fungicide Development Outlook in 2026

Growth Drivers, Risks, and Market Shifts

Fungicides still have solid long-term prospects, but the category is no longer defined by simple volume growth. The demand base remains strong because plant pests and diseases destroy up to 40% of global crop production each year and cost the global economy more than USD 220 billion. At the same time, the next phase of fungicide development is being reshaped by climate volatility, resistance pressure, biological innovation, and more uneven regional demand.

In other words, the future of fungicides is less about selling more of the same products and more about building stronger disease-control systems. The strongest growth signals now sit at the intersection of crop risk, stewardship, formulation value, and integrated disease management.

What is driving fungicide development in 2026?

Driver	Latest signal	What it means for the industry
Global disease pressure	Plant pests and diseases still destroy up to 40% of global crop production and cost over USD 220 billion annually	Fungicides remain strategically relevant, especially in yield-sensitive and high-value crops
Climate volatility	Rising temperatures, humidity shifts, and drought-flood cycles are accelerating fungal pressure and mycotoxin risk	Disease control demand is becoming more scenario-driven and weather-sensitive
Biological innovation	EPA says it registered 15 new biopesticide active ingredients since January 2025	Biological and reduced-risk solutions are becoming a more visible part of the innovation pipeline
Resistance management	FRAC says resistance management is driven by fungicide risk, pathogen risk, and agronomic risk	Product value increasingly depends on how well it fits long-term stewardship programs
Regional restructuring	EU pesticide sales fell to about 292,000 tonnes in 2023, yet fungicides and bactericides still represented 39% of total sales	Fungicides remain a major category, but growth is more uneven across regions and product types
Field-level return	USDA ARS reported yield gains from fungicide treatments ranging from 24.1% to 109.5% in a 2025 stripe rust trial	Performance-based use still creates strong on-farm value under disease pressure

The table above is built from the latest updates published by FAO, IPPC, Eurostat, EPA, FRAC, and USDA ARS. Taken together, these signals point to a category that remains important, but whose growth is becoming more selective, more technical, and more dependent on stewardship.

Why fungicides still matter in global agriculture

The most important reason is simple: disease pressure has not gone away. FAO continues to state that up to 40% of global crop production is lost each year to plant pests and diseases, with the economic cost exceeding USD 220 billion. That alone keeps fungicides strategically relevant in cereals, fruits, vegetables, vineyards, horticulture, and other disease-sensitive crop systems.

The broader crop protection market also remains large. FAO’s 2025 update says total pesticide use in agriculture reached 3.73 million tonnes of active ingredients in 2023, while total pesticide exports were valued at USD 42.8 billion. Those figures are not fungicide-only numbers, but they do show that plant protection remains a major global input category rather than a shrinking side market.

Climate pressure is expanding the long-term need for disease control

One of the clearest 2025 signals is that climate instability is increasing the complexity of plant health management. The International Plant Protection Convention says increasing temperatures, shifts in humidity, and cycles of drought and flooding are creating favorable conditions for fungi to grow and contaminate food, including through mycotoxin risk. It also says the behavior, severity, and spread of plant pests and pathogens are already changing, and that these changes are accelerating.

That matters because fungicide demand is no longer driven only by routine seasonal use. It is increasingly shaped by sudden disease windows, longer infection periods, regional weather instability, and stronger pressure to protect crop quality as well as yield. This does not guarantee uniform market expansion everywhere, but it does raise the long-term importance of reliable disease-control tools.

The future is not just more chemistry, but better segmentation

Older market commentary often treated fungicide prospects as a story of rising agricultural intensity and broader product use. That logic is now incomplete. The stronger signal in 2026 is segmentation: more value is moving toward crop-specific programs, mixture strategies, resistance-aware positioning, biological complements, and more disciplined use timing. This is an inference from the current data environment rather than a single-stat conclusion, but it is strongly supported by the way regulators, stewardship groups, and major suppliers are now describing the category.

This is also why “fungicide development prospects” should not be read as “all fungicide portfolios will grow at the same pace.” What looks promising today is not generic expansion. It is higher-value, better-targeted, and more stewardship-compatible growth.

Biological and reduced-risk products are becoming a real growth signal

One of the strongest recent indicators is regulatory and pipeline attention to biologicals. EPA announced in October 2025 that it had registered 15 new biopesticide active ingredients since January 2025. That number covers the wider biopesticide category, not fungicides alone, but it is still a strong signal that biological and reduced-risk crop protection products are moving through the innovation system at a meaningful pace.

The practical implication is not that biological fungicides will replace chemical fungicides across the board. The more realistic conclusion is that biologicals are becoming an important second layer in disease-management programs, especially where residue expectations, market access, resistance pressure, or sustainability requirements are higher. That is the kind of structural change that supports development prospects even when conventional volume growth is uneven.

Resistance management is now central to product value

A fungicide’s long-term commercial value is no longer defined only by efficacy at launch. FRAC’s 2025 Code List states that resistance management is driven by three factors: the intrinsic risk of the fungicide, pathogen risk, and agronomic risk. That means future product success depends not only on chemistry, but also on how well the product fits a durable management program.

This is a major reason the category still has development potential. Growers and technical teams do not just need products that work once. They need products that can be positioned within rotation strategies, mixtures, and crop-specific programs without accelerating resistance problems too quickly. In that environment, stewardship is not a side issue. It is part of the commercial proposition.

Europe shows both pressure and opportunity

The latest Eurostat data shows why fungicide prospects must be read carefully by region. In 2023, total pesticide sales in the EU fell to about 292,000 tonnes, the lowest level since the series began in 2011. Yet fungicides and bactericides still represented 39% of all pesticide sales, making them the largest product group by volume. Eurostat also reported that inorganic fungicides accounted for 62.9% of fungicides and bactericides sold in the EU in 2023.

This tells you two things at once. First, fungicides remain a major category in Europe. Second, the category is developing under tighter market and regulatory pressure, not in an unrestricted growth environment. So the opportunity is still there, but it is more likely to favor differentiated products, stronger positioning, and better compliance fit than broad-based volume expansion alone.

Regional demand is becoming more uneven, not more uniform

Company results also support the view that fungicide growth is becoming regionally uneven. BASF reported that fungicide sales in its Agricultural Solutions segment fell 5.8% in 2025, while Bayer said its fungicide business was below the prior-year level, with declines in North America and Asia/Pacific partly offset by higher volumes in Europe, the Middle East, and Africa. Those results do not define the whole market, but they do confirm that fungicide performance is increasingly shaped by region, weather, portfolio mix, currency, and market conditions rather than by one global trend line.

That is important for anyone assessing long-term prospects. A category can remain strategically strong while still producing volatile year-to-year performance in specific regions or product lines. The outlook is therefore positive in structural terms, but selective in commercial terms.

Field-level value still supports the category

Development prospects also depend on whether fungicides continue to deliver measurable agronomic value. USDA ARS published 2025 stripe rust trial results showing that significant yield increases from fungicide treatments ranged from 24.1% to 109.5% compared with the non-treated check. That kind of field response shows why fungicides remain commercially relevant in high-pressure situations.

This does not mean every fungicide application produces that kind of return. It does show, however, that when disease pressure is real and timing is correct, fungicides still protect economic value in a way that is very hard to replace. That is one of the strongest reasons the category continues to attract R&D, formulation work, and stewardship effort.

What could limit fungicide growth over the next few years?

The most obvious constraint is resistance pressure. If efficacy declines in key disease systems, even technically strong products become harder to position. FRAC’s 2025 framework makes clear that resistance is not a theoretical problem; it is built into how the category must now be managed.

The second constraint is regulation and market restructuring. Eurostat’s 2023 data shows lower overall pesticide sales in the EU, while supplier reports from 2025 show that fungicide sales can decline even inside large crop protection businesses. That does not cancel the category’s long-term value, but it does mean future growth will have to come from better fit, stronger stewardship, and more resilient product positioning.

The third constraint is that new growth will face more competition from alternative approaches. Biologicals, forecasting tools, crop-specific integrated programs, and tighter residue expectations will all influence how conventional fungicides are developed and sold. For some suppliers, that is a threat. For others, it is the next growth layer.

What the fungicide outlook really looks like from 2026 onward

The strongest conclusion is that fungicides still have a future, but not under the old assumptions. The category is supported by persistent disease pressure, climate-related plant health risk, and continued field value. At the same time, the winning part of the market is moving toward better segmentation, stronger resistance management, biological integration, and more precise program design.

So the development prospects are real, but they are now more quality-driven than quantity-driven. The next phase will favor fungicide products and fungicide programs that can prove three things at once: agronomic relevance, stewardship compatibility, and fit with a more regulated and more differentiated crop protection market.

FAQ

Are fungicides still a growth category in 2026?

Yes, but the growth story is more selective than before. Disease pressure, climate variability, and field-level value still support the category, while biologicals and stewardship-led programs are becoming a bigger part of future development.

Why is climate change important for fungicide demand?

Because rising temperatures, humidity shifts, and drought-flood cycles create better conditions for fungal development, food contamination, and changing disease spread. That increases the need for responsive disease-control programs.

Are biological fungicides replacing chemical fungicides?

Not broadly. The stronger evidence suggests that biologicals are becoming an important complement and innovation layer, not a universal replacement for conventional chemistry.

Why does resistance management matter so much for fungicide prospects?

Because long-term product value depends on whether a fungicide can stay useful inside real farming programs. FRAC’s 2025 guidance makes resistance management a core part of how fungicides must be evaluated and used.

Which market signal best explains the next phase of development?

There is no single signal, but the strongest combination is this: persistent global disease loss, climate-driven fungal risk, active biological innovation, and stronger stewardship requirements. Together, they support continued development while also changing what “growth” looks like.